Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis (AHOM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02344511
Recruitment Status : Withdrawn
First Posted : January 26, 2015
Last Update Posted : September 23, 2016
Sponsor:
Information provided by (Responsible Party):
Durata Therapeutics Inc., an affiliate of Allergan plc ( Durata Therapeutics International BV (an Affiliate of Actavis, Inc.) )

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : October 2018
  Estimated Study Completion Date : April 2019